Will the New 2026 Loss Table Cut a Federal Healthcare Fraud Sentence? What the $2 Billion Telemedicine Sentencings Mean for Florida Defendants

Will the New 2026 Loss Table Cut a Federal Healthcare Fraud Sentence? What the $2 Billion Telemedicine Sentencings Mean for Florida Defendants

If you are under federal investigation in a telemedicine, pharmacy, or durable medical equipment billing case, you have probably heard that the sentencing guidelines get softer on November 1, 2026. That is half true. The half that is false is the half that can cost you years.

The new loss table takes effect November 1, 2026. For high-loss telemedicine defendants, it changes almost nothing. The leverage lives elsewhere.

What Actually Happened

Two separate events collided this spring, and federal healthcare fraud defendants in Florida are standing at the intersection.

First, the sentencings. In May 2026, a federal judge in the Eastern District of New York imposed prison terms of 10 years, 120 months, and 97 months on three United States based members of a Moscow-run telemedicine and pharmacy scheme. According to the Justice Department announcement, call centers contacted insured patients, offered free medication with no real medical exam, and generated prescriptions in the names of recruited doctors and nurse practitioners. The group then bought up brick-and-mortar pharmacies through straw owners and used remote billers to submit the claims. Nearly $2 billion was billed. About $758 million was paid.

Second, the rule change. On April 16, 2026, the United States Sentencing Commission voted unanimously to adopt a package of guideline amendments without modification. The amendments went to Congress on May 1 and take effect November 1, 2026. They rewrite the economic-loss rules at the center of nearly every fraud sentence. They are not retroactive. Under U.S.S.G. section 1B1.11, they apply only to defendants sentenced on or after November 1, which means the three operators sentenced in May were measured by the old table, and the co-defendants still awaiting sentencing may not be.

What the Government Is Actually Building

The case did not come from a single United States Attorney's Office acting alone. It carries the fingerprints of the new National Fraud Enforcement Division, the consolidated fraud unit the Justice Department stood up in April 2026 and which the Department now credits in its healthcare fraud announcements. The Division pulls health care fraud and major fraud prosecutors into one structure and ties the work to a government-wide push against benefit-program fraud.

What that means in practice is consistency of method. Prosecutors start from third-party billing data, flag pharmacies and providers with anomalies, follow the money through shell entities and straw owners, then work outward to everyone who touched the operation. The architects are often offshore and out of reach. The people who get arrested and sentenced are the United States based operators: the billers, the logistics coordinators, the money movers, and the nominee pharmacy owners.

A 10-year sentence for a back-office biller is not an accident. It is the model.

The government also picked up a new tool this year. Beginning November 1, the guidelines allow an enhancement for noneconomic harm to victims, including physical and psychological harm. In a scheme where patients were prescribed drugs they never received, or received medication no physician actually evaluated them for, expect prosecutors to argue that the harm went beyond the insurer's checkbook. That argument did not exist in the guidelines before. It does now.

The old table ran 16 tiers. The new table runs 8. At the top of the scale, the simplification gives nothing back. A $758 million loss defendant sits at the ceiling under either version.

Exposure, the Statute Stack, and the November 1 Loss-Table Math

The charges in cases like this are predictable.

Health care fraud under 18 U.S.C. section 1347 carries up to 10 years per count, more if serious bodily injury or death results. Conspiracy under 18 U.S.C. section 1349 carries the same penalty as the underlying offense. Wire fraud under 18 U.S.C. section 1343 carries up to 20 years. The Anti-Kickback Statute, 42 U.S.C. section 1320a-7b, adds 10 years per count and mandatory program exclusion. Money laundering under 18 U.S.C. sections 1956 and 1957 stacks another 20 and 10 years on top.

The statutory maximums are not what drives the sentence. The loss amount under U.S.S.G. section 2B1.1 does.

This is where the November 1 change matters, and where it is widely misunderstood. The old table ran 16 tiers. The new table runs 8 and is built to be less severe, with thresholds adjusted for a decade of inflation. For a mid-range defendant, that genuinely helps. A loss figure that used to land on the wrong side of a tier line can now fall a step lower and shave levels off the calculation. For the line-level South Florida operator whose attributed loss is a slice of the total, the new table plus the inflation fix can pull the advisory range down.

Here is the part the headlines miss. At the top of the scale, the relief disappears. A defendant tied to $758 million in actual loss, or close to $2 billion in intended loss, sits at the highest tier under either version of the table. Cutting 16 tiers to 8 does nothing for someone already at the ceiling. The billion-dollar telemedicine defendant gets the same loss enhancement on November 2 that he would have gotten on October 31.

Anyone telling a high-loss client that the new guidelines will rescue the sentence is selling a fix that does not exist at that altitude.

Where Real Sentencing Leverage Lives Under the New Rules

Where the new rules do create leverage for serious cases is outside the loss table. The amendments add two mitigating factors.

One allows a two-level reduction when the defendant acted under pressure from an employer, a close relationship, a threat, or a personal vulnerability that made them easier to use. That describes a meaningful share of the operators in these schemes: people paid below-market wages, lied to about who they worked for, and slotted into a structure they did not design.

The second factor gives a reduction when, before learning of any investigation, the defendant stopped the conduct, tried to return money, or reported the offense.

Both are real arguments. Neither writes itself. They have to be built into the record early and presented in a sentencing memorandum that the court can act on.

The National Fraud Enforcement Division is staffed and moving. The May sentencings give prosecutors a concrete benchmark for every future case involving a United States based operator.

The New Noneconomic Harm Enhancement

Effective November 1, 2026, the guidelines allow an enhancement for noneconomic harm to victims, including physical and psychological harm.

In schemes where patients never received prescribed medication or were never properly evaluated by a physician, prosecutors can argue the damage went beyond the insurer's loss. It is a new tool that did not exist in the prior guidelines.

For South Florida telemedicine cases where prescriptions were generated for patients who never had a real visit, this enhancement is not theoretical. It is a tool prosecutors will reach for when the dollar loss alone does not feel like enough.

Critical Mistakes People Make Early

The same errors show up in nearly every federal healthcare fraud investigation, and each one narrows the defense before a lawyer gets involved.

Talking to agents without counsel. The HHS-OIG investigators who knock on your door are friendly until they are not. Anything you say goes in the file, and anything inconsistent becomes a false statement count under 18 U.S.C. section 1001. An HHS-OIG subpoena defense begins with silence and counsel, not with an explanation.

Producing documents without a strategy. Once a federal grand jury subpoena lands, every page you hand over shapes the indictment. Producing without privilege review or scope objections is how clients build the government's case for it.

Assuming the matter is not serious because no one has been charged. These cases run 18 to 36 months before an indictment unseals. By the time a federal target letter arrives, the United States Attorney's Office has been building the file for years.

Walking into a proffer unprepared. Sitting for a proffer without a negotiated agreement and a clear read on whether the government wants you as a witness or a defendant is how people talk themselves into charges.

The pre-indictment window is when the defense does its best work. After the indictment, the leverage shifts entirely to the government.

The Strategic Defense Approach

Early intervention does three things in a case shaped like this one.

It can shape the charging document. Engaging the line prosecutors before the indictment is final is sometimes how counts come off the table, how a loss-amount theory gets narrowed, and how money laundering exposure that adds years gets challenged before it is locked in. Pre-indictment defense work is where these cases are won, not at sentencing.

It controls the cooperation decision. The government needs operators to climb toward the architects. The first credible person through the door usually gets the best position. That decision has to be made with a clear-eyed read of the proffer terms and the client's actual exposure, not under pressure in an agent's interview room.

It positions the sentence before the sentence is written. If charges proceed, the loss calculation, the role adjustment, the new mitigating factors, and a 18 U.S.C. section 3553(a) variance argument all have to be developed and documented. For a defendant who can be sentenced on either side of November 1, the timing itself is a strategic question worth analyzing rather than leaving to the calendar.

Why Timing Matters Now

Three forces are converging on the same defendants.

The National Fraud Enforcement Division is staffed and moving. The Southern District of Florida remains one of the most active telehealth, pharmacy, and DME enforcement districts in the country. And the May sentencings give prosecutors a concrete benchmark to wave in front of any judge weighing a long term for a United States based operator.

The November 1 effective date adds a clock most defendants do not see. Whether a sentencing lands before or after that date changes which loss table applies and whether the new mitigating factors are available. For someone facing a near-certain plea, that timing can be worth months or years.

If you have been told you are a witness, received a federal grand jury subpoena, had HHS-OIG agents make contact, or learned that a pharmacy you owned or managed was flagged by an insurer, the investigation is already underway. The leverage you have shrinks with every week you wait.

Facing a Federal Healthcare Fraud or Telemedicine Investigation in Florida?

AMC Defense Law represents pharmacy owners, telehealth physicians, nurse practitioners, billing operators, marketers, and corporate officers in federal healthcare fraud investigations across the Southern and Middle Districts of Florida and nationwide. The firm's work is built on pre-indictment intervention, controlling the narrative before charges are filed, and disciplined sentencing positioning when charges proceed. Discretion is the rule. Every consultation is confidential.

Call 561.542.5494 or contact us through amcdefenselaw.com to schedule a confidential case review.

Disclaimer: This article is for general information only and does not constitute legal advice. Reading it does not create an attorney-client relationship. Every case turns on its own facts. If you are under investigation or facing federal charges, speak with a qualified federal criminal defense attorney about your specific situation. Prior outcomes do not guarantee future results.

If you or your loved ones have been arrested or are under federal investigation, call Aaron M. Cohen, 24 hours a day to get help.